507 doctors came together to create a blue circle, the universal symbol of diabetes to spread awareness
Research Society for the Study of Diabetes in India (RSSDI), Bengaluru 2014 and Ranbaxy Laboratories joined hands with doctors to form a blue circle, the universal symbol of diabetes, at the 42nd Annual Conclave, which was held recently organised by the Karnataka Chapter of RSSDI, Bengaluru.
Doctors participating in the national conference on diabetes were invited to hold each other’s hand and stand around the blue circle (modelled on the International Diabetes Federation’s blue circle) in concentric circles. For every doctor who formed the circle, RSSDI Bengaluru 2014 and Ranbaxy decided to adopt a juvenile diabetes patient for his/her insulin requirements for full one year.
Dr KR Narasimha Shetty, Director of Karnataka Institute of Diabetology and Chairman, of the Organizing committee, said, “The 42nd Annual Conclave of RSSDI is being attended by more than 6,000 doctor-delegates coming from different parts of India. Speakers from India and abroad are delivering talks on various aspects of diabetes with focus on multiple organ morbidity. Major purpose of the conclave is to evaluate the factors responsible for the increasing trend of Type-II diabetes that is being seen in India among the youth and children, and discuss the role of diabetes in cardiac dysfunction. The event provides a platform for medical experts in the field of diabetes to exchange notes and discuss latest research. I am therefore delighted that Ranbaxy has organised the blue circle event at the venue to increase awareness about juvenile diabetes in India among medical professionals and public alike. This would help a great deal in helping diagnose this disease in children earlier.”
At the RSSDI conclave, Ranbaxy launched its medical collaboration portal and gave a demonstration of Google Glass and how it can be of great help to the healthcare fraternity. The doctors were made better aware of apps and utilities such as video recording, taking photographs through glass, searching at google platform and interactive maps. Information was provided about value-added services of Ranbaxy such as Dial a diet / Dial a Sample, Medical and apps such as Fit heart and My Steps APP.
On the occasion, Rajeev Sibal, Vice President and Head, India region, Ranbaxy, said, “There are approximately 70,000 patients with Type I diabetes (juvenile diabetes) in India. Our intention behind forming the blue circle is to create awareness about the rising menace of diabetes in the society, especially juvenile diabetes. There is a common assumption that diabetes affects only adults, not children. Most child patients of Type I diabetes are not diagnosed on time due to a lack of awareness about this disease. We are very happy to organise the formation of the blue circle with the help of doctors to unite everyone in the fight against diabetes.”
Adding further, Sibal said, “RSSDI Bengaluru 2014 and Ranbaxy have committed to adopt juvenile diabetes patients in terms of their insulin requirement for a year. We would also contribute towards International Diabetes Federation’s ‘Life for a Child’ programme.’
Dr MR Mohan, Specialty Consultant, Karnataka Institute of Diabetology and Secretary of the Organizing committee, 42nd Annual Conclave, “I am excited to be a part of the blue circle organised by Ranbaxy on the sidelines of this conclave. I think this will go a long way in spreading awareness about diabetes in the country and make a difference to my patients and other people suffering from this disease.”
EP News Bureau – Mumbai
- Advertisement -